참고문헌
- Antoniou AC, Sinilnikova OM, McGuffog L, et al (2009). Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet, 18, 4442-56. https://doi.org/10.1093/hmg/ddp372
- Ashraf N, Zino S, MacIntyre A, et al (2006). Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer, 95, 1056-61. https://doi.org/10.1038/sj.bjc.6603384
- Brennan DJ, Gallagher WM (2008). Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'. Breast Cancer Res, 10, 102. https://doi.org/10.1186/bcr1854
-
Buroker NE, Huang J-Y, Barboza J, et al (2011). The adaptor-related protein complex 2, alpha 2 subunit (
$AP2{\alpha}2$ ) gene is a peroxisome proliferator-activated receptor cardiac target gene. Protein J, 31, 75-83. - Cancer CGoHFiB (2001). Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet, 358, 1389-99. https://doi.org/10.1016/S0140-6736(01)06524-2
- Cancer CGoHFiB (2002). Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease. Br J Cancer, 87, 1234-45. https://doi.org/10.1038/sj.bjc.6600596
- Cheng CJ, Lin YC, Tsai MT, et al (2009). SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. Cancer Res, 69, 3634-41. https://doi.org/10.1158/0008-5472.CAN-08-3615
- Chou HL, Yao CT, Su SL, et al (2013). Gene expression profiling of breast cancer survivability by pooled cDNA microarray analysis using logistic regression, artificial neural networks and decision trees. BMC Bioinformatics, 14, 1-11. https://doi.org/10.1186/1471-2105-14-1
- Easton DF (2002). Familial risks of breast cancer. Breast Cancer Res, 4, 1-3. https://doi.org/10.1186/bcr464
- Easton DF, Pooley KA, Dunning AM, et al (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-93. https://doi.org/10.1038/nature05887
- Fan C, Oh DS, Wessels L, et al (2006). Concordance among Gene-Expression-Based Predictors for Breast Cancer. N Engl J Med, 355, 560-9. https://doi.org/10.1056/NEJMoa052933
- Fornaro L, Lonardi S, Masi G, et al (2013). FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO). Ann Oncol, 24, 2062-7. https://doi.org/10.1093/annonc/mdt165
- Giltnane JM, Balko JM (2014). Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancer. Discov Med, 17, 275-83.
- Hannigan M, Zhan L, Ai Y, et al (2001). Leukocyte-specific gene 1 protein (LSP1) is involved in chemokine KC-activated cytoskeletal reorganization in murine neutrophils in vitro. J Leukoc Biol, 69, 497-504.
- Hirschey MD, Shimazu T, Goetzman E, et al (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature, 464, 121-5. https://doi.org/10.1038/nature08778
- Howard TH, Hartwig J, Cunningham C (1998). Lymphocyte-specific protein 1 expression in eukaryotic cells reproduces the morphologic and motile abnormality of NAD 47/89 neutrophils. Blood, 91, 4786-95.
- Irahara N, Baba Y, Nosho K, et al (2010). NRAS mutations are rare in colorectal cancer. Diagn Mol Pathol, 19, 157-63. https://doi.org/10.1097/PDM.0b013e3181c93fd1
- Jiang Y, Shen H, Liu Xa, et al (2011). Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women. PLoS ONE, 6, e21563. https://doi.org/10.1371/journal.pone.0021563
- Kim HS, Patel K, Muldoon-Jacobs K, et al (2010). SIRT3 Is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during Stress. Cancer Cell, 17, 41-52. https://doi.org/10.1016/j.ccr.2009.11.023
- Kincaid B, Bossy-Wetzel E (2013). Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front Aging Neurosci, 5, 48.
- Li-Weber M (2013a). Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett, 332, 304-12. https://doi.org/10.1016/j.canlet.2010.07.015
- Li-Weber M (2013b). Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett, 332, 304-12. https://doi.org/10.1016/j.canlet.2010.07.015
- Lin Y-C, Chen C-C, Cheng C-J, et al (2011). Domain and functional analysis of a novel breast tumor suppressor protein, SCUBE2. J Biol Chem, 286, 27039-47. https://doi.org/10.1074/jbc.M111.244418
- Lin YC, Lee YC, Li LH, et al (2014). Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. J Cell Sci, 127, 85-100. https://doi.org/10.1242/jcs.132779
-
McKinney C, Fanciulli M, Merriman ME, et al (2010). Association of variation in
$Fc{\gamma}$ receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis, 69, 1711-6. https://doi.org/10.1136/ard.2009.123588 - Membrino A, Cogoi S, Pedersen EB, et al (2011). G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy. PLoS ONE, 6, e24421. https://doi.org/10.1371/journal.pone.0024421
- Ozer E, Sis B, Ozen E, et al (2000). BRCA1, C-erbB-2, and H-ras gene expressions in young women with breast cancer: an immunohistochemical study. Appl Immunohistochem Mol Morphol, 8, 8-12.
- Patani N, Martin LA, Dowsett M (2013). Biomarkers for the clinical management of breast cancer: international perspective. Int J Cancer, 133, 1-13. https://doi.org/10.1002/ijc.27997
- Qiu X, Brown K, Hirschey MD, et al (2010). Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 Activation. Cell Metab, 12, 662-7. https://doi.org/10.1016/j.cmet.2010.11.015
- Saini KS, Loi S, de Azambuja E, et al (2013). Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat Rev, 39, 935-46. https://doi.org/10.1016/j.ctrv.2013.03.009
- Schubbert S, Shannon K, Bollag G (2007). Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer, 7, 295-308. https://doi.org/10.1038/nrc2109
-
Scorilas A, Levesque MA, Ashworth LK, et al (2002). Cloning, physical mapping and structural characterization of the human
${\alpha}A$ -adaptin gene. Gene, 289, 191-9. https://doi.org/10.1016/S0378-1119(02)00504-8 - Shi T, Wang F, Stieren E, et al (2005). SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem, 280, 13560-7. https://doi.org/10.1074/jbc.M414670200
- Skrzypczak M, Lattrich C, Häring J, et al (2013). Expression of SCUBE2 gene declines in high grade endometrial cancer and associates with expression of steroid hormone receptors and tumor suppressor PTEN. Gynecol Endocrinol, 29, 1031-5. https://doi.org/10.3109/09513590.2013.829441
- Someya S, Yu W, Hallows WC, et al (2012). Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under Caloric restriction. Cell, 143, 802-12.
- Stacey SN, Manolescu A, Sulem P, et al (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet, 39, 865-9. https://doi.org/10.1038/ng2064
- Taghavi A, Fazeli Z, Vahedi M, et al (2012). Increased Trend of Breast Cancer Mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70. https://doi.org/10.7314/APJCP.2012.13.1.367
- Tsai M-T, Cheng C-J, Lin Y-C, et al (2009). Isolation and characterization of a secreted, cell-surface glycoprotein SCUBE2 from humans. Biochem J, 422, 119-28. https://doi.org/10.1042/BJ20090341
- Vaziri H, Dessain SK, Eaton EN, et al (2001). em hSIR2 sup SIRT1 sup em Functions as an NAD-Dependent p53 Deacetylase. Cell, 107, 149-59. https://doi.org/10.1016/S0092-8674(01)00527-X
- Yang R-B, Ng CKD, Wasserman SM, et al (2002). Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J BiolChem, 277, 46364-73.
- Young A, Lou D, McCormick F (2013). Oncogenic and wild-type ras play divergent roles in the regulation of mitogen-activated protein kinase signaling. Cancer Discov, 3, 112-23.